Atossa Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATOS and other ETFs, options, and stocks.

About ATOS

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests.

CEO

Steven C. Quay

CEOSteven C. Quay

Employees

Employees8

Headquarters

Seattle, Washington

HeadquartersSeattle, Washington

Founded

2008

Founded2008

Employees

Employees8

ATOS Key Statistics

Market cap

105.53M

Market cap105.53M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

429.78K

Average volume429.78K

High today

$0.85

High today$0.85

Low today

$0.8203

Low today$0.8203

Open price

$0.83

Open price$0.83

Volume

245.14K

Volume245.14K

52 Week high

$3.33

52 Week high$3.33

52 Week low

$0.7972

52 Week low$0.7972

ATOS Earnings

-$0.06

-$0.04

-$0.02

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 9, After Hours

ActualExpected Nov 9, After Hours

Atossa Therapeutics

Why Robinhood?

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests. Show more

ATOS Key Statistics

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests.